Jayaganesh V. Natarajan

Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye

M. Ang, S. Venkatraman, S. Chattopadhyay, 2012, International journal of nanomedicine.

Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucoma.

Marcus Ang, Subbu S Venkatraman, M. Ang, 2014, ACS nano.

Polymer- and liposome-based nanoparticles in targeted drug delivery.

Sujay Chattopadhyay, Subbu S Venkatraman, S. Venkatraman, 2010, Frontiers in bioscience.

Drug, delivery and devices for diabetic retinopathy (3Ds in DR)

T. Lim, R. Agrawal, A. Laude, 2016, Expert opinion on drug delivery.

Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops

S. Venkatraman, G. Novack, T. Wong, 2014, Drug Delivery and Translational Research.

Sustained-release from nanocarriers: a review.

S. Venkatraman, C. Nugraha, X. Ng, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Sustained Release of an Anti-Glaucoma Drug: Demonstration of Efficacy of a Liposomal Formulation in the Rabbit Eye

M. Ang, S. Foo, S. Venkatraman, 2011, PloS one.

Folate targeting of drug carriers: a mathematical model.

Justin Saul, Ketan B Ghaghada, Ravi V Bellamkonda, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Controlled targeting of liposomal doxorubicin via the folate receptor in vitro.

Ananth Annapragada, Ravi V Bellamkonda, R. Bellamkonda, 2003, Journal of controlled release : official journal of the Controlled Release Society.

Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab

R. Agrawal, S. Venkatraman, T. Wong, 2017, Scientific Reports.

International Journal of Nanomedicine Dovepress Nanomedicine for Glaucoma: Liposomes Provide Sustained Release of Latanoprost in the Eye

M. Ang, S. Chattopadhyay, T. Wong, 2022 .